Selective Information Borrowing for Region-Specific Treatment Effect Inference under Covariate Mismatch in Multi-Regional Clinical Trials

2026-02-02

AI Summary

This study addresses the challenge of estimating region-specific treatment effects in multi-regional clinical trials when the target region has a small sample size and exhibits covariate or unobserved confounding differences relative to auxiliary regions, leading to biased and inefficient estimates. The authors propose a unified causal inference framework that selectively borrows information from auxiliary regions through conformal prediction–driven patient-level comparability screening. By integrating inverse-variance weighting with a selection-aware conditional randomization test, the method enhances estimation efficiency while rigorously controlling Type I error. It effectively combines rich-covariate data from small samples with limited-covariate data from large samples, achieving double robustness. Simulations demonstrate a 10–50% reduction in mean squared error and substantially improved statistical power, and application to the POWER trial confirms meaningful gains in estimation precision.

Technology Category

• Machine Learning: Causal Learning
• Intelligent Robots: State Estimation
• Reasoning under Uncertainty: Causality

Application Category

• User Modeling, Personalization and Recommendation: Attacks and countermeasures in recommendation systems
• Security and Privacy: Large-scale security measurements
• Search and Retrieval-Augmented AI: Web learning to rank, online learning, and counterfactual learning for ranking

Abstract

Multi-regional clinical trials (MRCTs) are central to global drug development, enabling evaluation of treatment effects across diverse populations. A key challenge is valid and efficient inference for a region-specific estimand when the target region is small and differs from auxiliary regions in baseline covariates or unmeasured factors. We adopt an estimand-based framework and focus on the region-specific average treatment effect (RSATE) in a prespecified target region, which is directly relevant to local regulatory decision-making. Cross-region differences can induce covariate shift, covariate mismatch, and outcome drift, potentially biasing information borrowing and invalidating RSATE inference. To address these issues, we develop a unified causal inference framework with selective information borrowing. First, we introduce an inverse-variance weighting estimator that combines a"small-sample, rich-covariate"target-only estimator with a"large-sample, limited-covariate"full-borrowing doubly robust estimator, maximizing efficiency under no outcome drift. Second, to accommodate outcome drift, we apply conformal prediction to assess patient-level comparability and adaptively select auxiliary-region patients for borrowing. Third, to ensure rigorous finite-sample inference, we employ a conditional randomization test with exact, model-free, selection-aware type I error control. Simulation studies show the proposed estimator improves efficiency, yielding 10-50% reductions in mean squared error and higher power relative to no-borrowing and full-borrowing approaches, while maintaining valid inference across diverse scenarios. An application to the POWER trial further demonstrates improved precision for RSATE estimation.

Problem

• region-specific treatment effect
• covariate mismatch
• multi-regional clinical trials
• information borrowing
• outcome drift

Innovation

• selective information borrowing
• region-specific treatment effect
• conformal prediction
• conditional randomization test
• covariate mismatch